Company: ICUI
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000883984-25-000016
Chunk: 33

Company: ICU MEDICAL INC/DE
Filing Date: 2025-05-08
Form: 10-Q
Item: Item 1
Chunk 33
---
471)NET LOSS PER SHARE  Basic$(0.63)$(1.63)Diluted$(0.63)$(1.63)WEIGHTED AVERAGE NUMBER OF SHARES  Basic24,539 24,222 Diluted24,539 24,222 

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Table of Contents

ICU MEDICAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)

(In thousands)

 Three months ended March 31, 20252024NET LOSS$(15,476)$(39,471)Other comprehensive income (loss), net of tax:Cash flow hedge adjustments, net of tax of $(1,832) and $2,029 for the three months ended March 31, 2025 and 2024, respectively.(5,884)6,360 Foreign currency translation adjustment, net of tax of $0 for all periods39,890 (22,817)Other comprehensive income (loss), net of tax34,006 (16,457)COMPREHENSIVE INCOME (LOSS)$18,530 $(55,928)

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

ICU MEDICAL, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited)

(Amounts in thousands)

Common StockAdditionalPaid-inCapitalTreasuryStockRetainedEarningsAccumulatedOtherComprehensiveLossSharesAmountTotalBalance, January 1, 202524,518 $2,452 $1,412,118 $(92)$690,158 $(139,401)$1,965,235 Issuance of restricted stock and exercise of stock options152 9 (8,299)8,423 — — 133 Tax withholding payments related to net share settlement of equity awards(59)— — (8,391)— — (8,391)Stock compensation— — 12,179 — — — 12,179 Other comprehensive income, net of tax— — 3 — — 34,006 34,009 Net loss— — — — (15,476)— (15